Volume 26, Issue 119 (November & December 2018)                   J Adv Med Biomed Res 2018, 26(119): 12-16 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Eftekhari S S, Hejazi S A, Sharifipour E, Hejazi S F, Talebizadeh M, Mostafavi H et al . Cognitive Impairment in Patients with Coronary Artery Disease; Comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE). J Adv Med Biomed Res. 2018; 26 (119) :12-16
URL: http://zums.ac.ir/journal/article-1-5142-en.html
1- Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran
2- Dept. of Cardiology, Faculty of Medicine, Qom University of Medical Sciences, Qom, Iran
3- Dept. of Physiology and Pharmacology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
4- Neuroscience Research Center, Spiritual Health Research Center, Qom University of Medical Sciences, Qom, Iran , syoosefee@muq.ac.ir
Abstract:   (1848 Views)
Background & Objective:  Mild cognitive impairment (MCI) is a transient state between normal condition and dementia. Available data indicates that coronary artery diseases (CAD) may increase the risk of MCI. Hence, the early detection of MCI can prevent the progression of cognitive decline.
Materials & Methods:  A sample of 65 subjects with degrees of CAD was enrolled to the study. For cognitive assessment, Mini Mental State Examination and Montreal Cognitive Assessment were used. Sensitivity, specificity, Positive Predictive Value (PPV), and Negative Predictive Value (NPV) of MoCA were assessed in the cut-off points of 26 and 25. The SPSS 22 was used for data analysis. The statistical significance was set at P-value<0.05.
Results:  The prevalence of cognitive impairment was calculated 41.5% and between 47.7% and 60% by MMSE and MoCA, respectively. At the cut-off point of 25 for MoCA test, the sensitivity and specificity were 92.6% and 84.2%, and PPV and NPV were 80.6% and 94.1%, respectively, and the efficacy of MoCA test for the detection of MCI was 87.69%. At the cut-off point of 26 for MoCA test, the sensitivity and specificity were 96.3% and 65.8%, and PPV and NPV were 66.7% and 96.2%, respectively, and the efficacy of MoCA test was 78.46%.
Conclusion:  The prevalence of MCI in patients with CAD was higher than what was previously reported. The MoCA was more sensitive for recognizing the MCI in these patients. We suggested the cut-off point of 25 for the higher accuracy of the MoCA in detecting MCI in CAD patients.
Full-Text [PDF 339 kb]   (815 Downloads) |   |   Full-Text (HTML)  (110 Views)  
✅ The prevalence of MCI in patients with CAD was higher than what was previously reported. The MoCA was more sensitive for recognizing the MCI in these patients. We suggested the cut-off point of 25 for the higher accuracy of the MoCA in detecting MCI in CAD patients.
Type of Study: Original | Subject: Clinical medicine
Received: 2018/04/12 | Accepted: 2018/09/15 | Published: 2019/08/18

1. Gauthier S, Reisberg B, Zaudig M, et al. Mild cognitive impairment. The Lancet. 2006; 367(9518): 1262-70. [DOI:10.1016/S0140-6736(06)68542-5]
2. McLennan S, Mathias J, Brennan L, Stewart S. Validity of the montreal cognitive assessment (MoCA) as a screening test for mild cognitive impairment (MCI) in a cardiovascular population. J Geriatr Psychiatry Neurol. 2011; 24(1): 33-8. [DOI:10.1177/0891988710390813] [PMID]
3. Mariani E, Monastero R, Ercolani S, Rinaldi P, Mangialasche F, Costanzi E, et al. Influence of comorbidity and cognitive status on instrumental activities of daily living in amnestic mild cognitive impairment: results from the ReGAl project. Int J Geriat Psychiat. 2008; 23(5): 523-30. [DOI:10.1002/gps.1932] [PMID]
4. Pereira F, Yassuda M, Oliveira A, Forlenza O. Executive dysfunction correlates with impaired functional status in older adults with varying degrees of cognitive impairment. Int J Psychogeriat. 2008; 20(6): 1104-15. [DOI:10.1017/S1041610208007631] [PMID]
5. Kim KR, Lee KS, Cheong HK, Eom JS, Oh BH, Hong CH. Characteristic profiles of instrumental activities of daily living in different subtypes of mild cognitive impairment. Dement Geriatr Cogn Disord. 2009; 27(3): 278-85. [DOI:10.1159/000204765] [PMID]
6. Roberts RO, Geda YE, Knopman DS, et al. The incidence of MCI differs by subtype and is higher in men The Mayo Clinic Study of Aging. Neuro logy. 2012. 78(5): 342-51. [DOI:10.1212/WNL.0b013e3182452862] [PMID] [PMCID]
7. Petersen RC, Roberts RO, Knopman DS, et al. Prevalence of mild cognitive impairment is higher in men The Mayo Clinic Study of Aging. Neurol. 2010; 75(10): 889-97. [DOI:10.1212/WNL.0b013e3181f11d85] [PMID] [PMCID]
8. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch General Psychiat. 2006; 63(3): 273-9. [DOI:10.1001/archpsyc.63.3.273] [PMID]
9. Kivipelto M, Helkala E-L, Hänninen T, et al. Midlife vascular risk factors and late-life mild cognitive impairment a population-based study. Neurol. 2001; 56(12): 1683-9. [DOI:10.1212/WNL.56.12.1683] [PMID]
10. Volonghi I, Pendlebury ST, Welch SJ, Mehta Z, Rothwell PM. Cognitive outcomes after acute coronary syndrome: a population based comparison with transient ischaemic attack and minor stroke. Heart. 2013: 99(20): 1509-14. [DOI:10.1136/heartjnl-2013-304207] [PMID]
11. Muqtadar H, Testai FD, Gorelick PB. The dementia of cardiac disease. Curr Cardiol Rep. 2012; 14(6): 732-40. [DOI:10.1007/s11886-012-0304-8] [PMID]
12. Eggermont LH, de Boer K, Muller M, Jaschke AC, Kamp O, Scherder EJ. Cardiac disease and cognitive impairment: a systematic review. Heart. 2012: 98(18): 1334-40. [DOI:10.1136/heartjnl-2012-301682] [PMID]
13. Abete P, Della-Morte D, Gargiulo G, et al. Cognitive impairment and cardiovascular diseases in the elderly. A heart-brain continuum hypothesis. Age Res Rev. 2014; 18: 41-52. [DOI:10.1016/j.arr.2014.07.003] [PMID]
14. Cameron J, Worrall-Carter L, Page K, Stewart S, Ski CF. Screening for mild cognitive impairment in patients with heart failure: Montreal Cognitive Assessment versus Mini Mental State Exam. Europ J Cardiovasc Nurs. 2013; 12(3): 252-60. [DOI:10.1177/1474515111435606] [PMID]
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 1975; 12(3): 189-98. [DOI:10.1016/0022-3956(75)90026-6]
16. Salzwedel A, Heidler M-D, Haubold K, et al. Prevalence of mild cognitive impairment in employable patients after acute coronary event in cardiac rehabilitation. Vasc Health Risk Manag. 2017; 13: 55. [DOI:10.2147/VHRM.S121086] [PMID] [PMCID]
17. Lu D, Li P, Zhou Y, et al. Association between serum non-high-density lipoprotein cholesterol and cognitive impairment in patients with acute ischemic stroke. BMC Neurol. 2016; 16(1): 154. [DOI:10.1186/s12883-016-0668-2] [PMID] [PMCID]
18. Mazzucco S, Li L, Tuna MA, et al. Hemodynamic correlates of transient cognitive impairment after transient ischemic attack and minor stroke: A transcranial Doppler study. Int J Stroke. 2016; 11(9): 978-86. [DOI:10.1177/1747493016661565] [PMID] [PMCID]
19. Lim KB, Kim J, Lee HJ, Yoo J, You EC, Kang J. Correlation between montreal cognitive assessment and functional outcome in subacute stroke patients with cognitive dysfunction. Ann Rehabil Med. 2018; 42(1): 26-34. [DOI:10.5535/arm.2018.42.1.26] [PMID] [PMCID]
20. Nasreddine ZS, Phillips NA, Bédirian V, et al. The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005; 53(4): 695-9. [DOI:10.1111/j.1532-5415.2005.53221.x] [PMID]
21. Zadikoff C, Fox SH, Tang‐Wai DF, et al. A comparison of the mini mental state exam to the Montreal cognitive assessment in identifying cognitive deficits in Parkinson's disease. Movement Disorders. 2008; 23(2): 297-9. [DOI:10.1002/mds.21837] [PMID]
22. Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the mini-mental state examination by age and educational level. JAMA. 1993; 269(18): 2386-91. https://doi.org/10.1001/jama.269.18.2386 [DOI:10.1001/jama.1993.03500180078038] [PMID]
23. Sikaroodi H, Yadegari S, Miri SR. Cognitive impairments in patients with cerebrovascular risk factors: a comparison of Mini Mental Status Exam and Montreal Cognitive Assessment. Clin Neurol Neurosurge. 2013; 115(8): 1276-80. [DOI:10.1016/j.clineuro.2012.11.026] [PMID]
24. Pohjasvaara T, Mäntylä R, Aronen HJ, et al. Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort. J Neurol Neurosurg Psychiat. 1999; 67(6): 742-8. [DOI:10.1136/jnnp.67.6.742] [PMID] [PMCID]
25. Dong Y, Sharma VK, Chan BP-L, et al. The Montreal Cognitive Assessment (MoCA) is superior to the Mini-Mental State Examination (MMSE) for the detection of vascular cognitive impairment after acute stroke. J Neuro Sci. 2010; 299(1-2): 15-8. [DOI:10.1016/j.jns.2010.08.051] [PMID]
26. Nys G, Van Zandvoort M, De Kort P, Jansen B, Kappelle L, De Haan E. Restrictions of the mini-mental state examination in acute stroke. Arch Clin Neuropsychol. 2005; 20(5): 623-9. [DOI:10.1016/j.acn.2005.04.001] [PMID]
27. Hawkins MA, Gathright EC, Gunstad J, et al. The MoCA and MMSE as screeners for cognitive impairment in a heart failure population: a study with comprehensive neuropsychological testing. Heart & Lung. J Acute Crit Care. 2014; 43(5): 462-8. [DOI:10.1016/j.hrtlng.2014.05.011] [PMID] [PMCID]
28. Athilingam P, King KB, Burgin SW, Ackerman M, Cushman LA, Chen L. Montreal Cognitive Assessment and Mini-Mental Status Examination compared as cognitive screening tools in heart failure. Heart & Lung. J Acute Crit Care. 2011; 40(6): 521-9. [DOI:10.1016/j.hrtlng.2010.11.002] [PMID]
29. Alexander M, Perera G, Ford L, et al. Age-stratified prevalence of mild cognitive impairment and dementia in European populations: a systematic review. J Alzheimer Disease. 2015; 48(2): 355-9. [DOI:10.3233/JAD-150168] [PMID]
30. Joo SH, Yun SH, Kang DW, Hahn CT, Lim HK, Lee CU. Body Mass Index in Mild Cognitive Impairment According to Age, Sex, Cognitive Intervention and Hypertension and Risk of Progression to Alzheimer's Disease. Front Psychiatry. 2018; 9: 142. [DOI:10.3389/fpsyt.2018.00142] [PMID] [PMCID]
31. Mathys J, Gholamrezaee M, Henry H, von Gunten A, Popp J. Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia. Experiment Gerontol. 2017; 100: 45-53. [DOI:10.1016/j.exger.2017.10.013] [PMID]
32. Cova I, Clerici F, Rossi A, et al. Weight loss predicts progression of mild cognitive impairment to Alzheimer's disease. PloS one. 2016; 11: e0151710. [DOI:10.1371/journal.pone.0151710] [PMID] [PMCID]

Add your comments about this article : Your username or Email:

Send email to the article author

© 2020 All Rights Reserved | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb  Co-Publisher: Farname Inc.